October 01, 2023 — Copenhagen, Denmark — Radiobotics, a leader in AI for musculoskeletal (MSK) radiology, announces the appointment of Peter Ulvskjold as Chief Executive Officer. Peter joins Radiobotics with a mandate to accelerate the company’s commercial strategy, expand market reach, and bring its suite of AI-powered solutions to new healthcare environments globally.
Peter Ulvskjold brings over 20 years of pharma and medtech experience, focusing on enhancing operational efficiency and global commercialization. Peter has a strong track record across international markets in senior management roles at Novo Nordisk, ConvaTec, and most recently as CEO for the Swedish biotech Atlas Antibodies.
“I am thrilled to join Radiobotics as its new CEO. The company has a disruptive radiology AI technology that will — and is — already improving patient outcomes. The organisation has over the past years built an industry leading platform, and now it is time for global commercialisation and bringing this revolutionary technology to the medical field internationally. I am honoured to help build that and lead our dedicated team towards even greater success”
Peter’s appointment comes as Radiobotics builds on a year of growth, including the expansion of its flagship product, RBfracture™, an AI-powered tool that identifies trauma-related findings with precision. Recognized for its potential to reduce missed fractures by up to 86%, RBfracture is currently deployed in hospitals across Europe and is continuing to make strides toward global expansion.
Mads Jarner Brevadt, Co-founder and acting CEO adds:
“I am personally very impressed by Peter, and I believe that he is the perfect match for Radiobotics, taking charge of the next step of the company’s development and ambitions towards being a specialised leader in the AI radiology space. The entire team and I are looking very much forward to welcome him onboard.”
Mads Jarner Brevadt will now enter the role as COO where he in close partnership with Peter Ulvskjold and the rest of the management team will execute on Radiobotics’ commercial and international ambitions.
About Radiobotics:
Founded in 2017, Radiobotics is an award-winning MedTech company dedicated to advancing musculoskeletal (MSK) radiology with AI-powered solutions. Radiobotics’ flagship solution, RBfracture™, is designed to support Emergency and Radiology with highly accurate detection of trauma-related findings, including fractures, dislocations, lipohemarthrosis, and effusions.
Radiobotics’ commitment to delivering precise, expert-level care in MSK imaging 24/7, regardless of time, infrastructure, or staffing constraints, has been recognized in the industry with numerous accolades, including Best New Radiology Vendor at the EuroMinnies 2022, a nomination for Digital Europe’s Future Unicorn Award in 2021, and a 2020 EIC Accelerator grant.
